Abstract
Background
Breast cancer, an emerging global challenge, is evidenced by recent studies of miRNAs
involvement in DNA repair gene variants (MRE11, RAD50, and NBN as checkpoint sensor
genes (CSG) – MRN-CSG). The identification of various mutations in MRN-CSG and their
interactions with miRNAs is still not understood. The emerging studies of miR-2909
involvement in other cancers led us to explore its role as molecular mechanistic marker
in breast cancer.
Materials and Methods
The genomic and proteomic data of MRN-CSG of breast cancer patients (8426 samples)
was evaluated to identify the mutation types linked with the patient's survival rate.
Additionally, molecular, 3D-structural and functional analysis was performed to identify
miR-2909 as regulator of MRN-CSG.
Results
The genomic and proteomic data analysis shows genetic alterations with majority of
missense mutations [RAD50 (0.7%), MRE11 (1.5%), and NBN (11%)], though with highest
MRE11 mRNA expression in invasive ductal breast carcinoma as compared to other breast
cancer types. The Kaplan–Meier survival curves suggest higher survival rate for unaltered
groups as compared to the altered group. Network analysis and disease association
of miR-2909 and MRN-CSG shows strong interactions with other partners. The molecular
hybridization between miR-2909-RAD50 and miR-2909-MRE11 complexes showed thermodynamically
stable structures. Further, argonaute protein, involved in RNA silencing, docking
studies with miR-MRE11-mRNA and miR-RAD50-mRNA hybridized complexes showed strong
binding affinity.
Conclusion
The results suggest that miR-2909 forms strong thermodynamically stable molecular
hybridized complexes with MRE11 and RAD50 mRNAs which further strongly interacts with
argonaute protein to show potential molecular mechanistic role in breast cancer.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical Breast CancerAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The changing global patterns of female breast cancer incidence and mortality.Breast Cancer Res. 2004; 6: 229https://doi.org/10.1186/bcr932
- Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis.Genes Dis. 2018; 5: 77-106https://doi.org/10.1016/j.gendis.2018.05.001
- DNA repair mechanisms in cancer development and therapy.Front Genet. 2015; 6https://doi.org/10.3389/fgene.2015.00157
- MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment.Mol Cancer. 2019; 18: 169https://doi.org/10.1186/s12943-019-1100-5
- Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene.Mol Oncol. 2008; 2: 296-316https://doi.org/10.1016/j.molonc.2008.09.007
- ATM-mediated DNA double-strand break response facilitated oncolytic Newcastle disease virus replication and promoted syncytium formation in tumor cells.PLoS Pathog. 2020; 16e1008514https://doi.org/10.1371/journal.ppat.1008514
- Breast cancer risk is associated with the genes encoding the dna double-strand break repair mre11/rad50/nbs1 complex.Cancer Epidemiol Biomark Prev. 2007; 16: 2024-2032https://doi.org/10.1158/1055-9965.EPI-07-0116
- The mre11–rad50–nbs1 complex conducts the orchestration of damage signaling and outcomes to stress in dna replication and repair.Annu Rev Biochem. 2018; 87: 263-294https://doi.org/10.1146/annurev-biochem-062917-012415
- Integrative network and computational simulation of clinical and genomic data for the identification of mutated EGFR in breast cancer patients for therapeutic targeting using purine analogues.Mol Simul. 2022; (Published online August 5): 1-13https://doi.org/10.1080/08927022.2022.2107638
- Screening and identification of phytochemical drug molecules against mutant BRCA1 receptor of breast cancer using computational approaches.Mol Cell Biochem. 2022; 477: 885-896https://doi.org/10.1007/s11010-021-04338-4
- MicroRNA regulation of the MRN complex impacts DNA damage, cellular senescence, and angiogenic signaling.Cell Death Dis. 2018; 9: 632https://doi.org/10.1038/s41419-018-0690-y
- Role of microRNAs in breast cancer.Cancer Biol Ther. 2013; 14: 201-212https://doi.org/10.4161/cbt.23296
- Role of micrornas in the development of cardiovascular disease in systemic autoimmune disorders.IJMS. 2020; 21: 2012https://doi.org/10.3390/ijms21062012
- Micrornas involved in carcinogenesis, prognosis, therapeutic resistance, and applications in human triple-negative breast cancer.Cells. 2019; 8: 1492https://doi.org/10.3390/cells8121492
- Cellular AATF gene encodes a novel miRNA that can contribute to HIV-1 latency.Indian J Biochem Biophys. 2009; 46: 237-240
- miR-2909-mediated regulation of KLF4: a novel molecular mechanism for differentiating between B-cell and T-cell pediatric acute lymphoblastic leukemias.Mol Cancer. 2014; 13: 175
- An androgen-regulated miR-2909 modulates TGFβ signaling through AR/miR-2909 axis in prostate cancer.Gene. 2017; 631: 1-9
- Prediction of recurrence of non-muscle invasive bladder cancer: the role of androgen receptor and miRNA-2909.Urol Oncol. 2022; 40 (-197.e35): 197.e25
- Regulation of cellular Cyclin D1 gene by arsenic is mediated through miR-2909.Gene. 2013; 522: 60-64
- Arsenic programmes cellular genomic-immunity through miR-2909 RNomics.Gene. 2014; 536: 326-331https://doi.org/10.1016/j.gene.2013.12.004
- Overview of microrna biogenesis, mechanisms of actions, and circulation.Front Endocrinol. 2018; 9: 402https://doi.org/10.3389/fendo.2018.00402
- Micrornas associated with the different human argonaute proteins.Nucleic Acids Res. 2012; 40: 9850-9862https://doi.org/10.1093/nar/gks705
- The cbio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.Cancer Discov. 2012; 2: 401-404https://doi.org/10.1158/2159-8290.CD-12-0095
- Predicting effective microRNA target sites in mammalian mRNAs.eLife. 2015; 4: e05005https://doi.org/10.7554/eLife.05005
- RNAhybrid: microRNA target prediction easy, fast and flexible.Nucleic Acids Res. 2006; 34 (Web Server): W451-W454https://doi.org/10.1093/nar/gkl243
- ViennaRNA Package 2.0.Algorithms Mol Biol. 2011; 6: 26https://doi.org/10.1186/1748-7188-6-26
- Web-Beagle: a web server for the alignment of RNA secondary structures: figure 1.Nucleic Acids Res. 2015; 43: W493-W497https://doi.org/10.1093/nar/gkv489
- Fast and effective prediction of microRNA/target duplexes.RNA. 2004; 10: 1507-1517
- MolProbity: More and better reference data for improved all-atom structure validation: PROTEIN SCIENCE.ORG.Protein Sci. 2018; 27: 293-315https://doi.org/10.1002/pro.3330
- HMDD v2.0: a database for experimentally supported human microRNA and disease associations.Nucleic Acids Res. 2014; 42: D1070-D1074https://doi.org/10.1093/nar/gkt1023
- MIENTURNET: an interactive web tool for microRNA-target enrichment and network-based analysis.BMC Bioinform. 2019; 20: 545https://doi.org/10.1186/s12859-019-3105-x
- The BioGRID interaction database: 2019 update.Nucleic Acids Res. 2019; 47: D529-D541https://doi.org/10.1093/nar/gky1079
- SWISS-MODEL: homology modelling of protein structures and complexes.Nucleic Acids Res. 2018; 46: W296-W303https://doi.org/10.1093/nar/gky427
- Deviations from standard atomic volumes as a quality measure for protein crystal structures.J Mol Biol. 1996; 264: 121-136https://doi.org/10.1006/jmbi.1996.0628
- ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules.Nucleic Acids Res. 2016; 44: W344-W350https://doi.org/10.1093/nar/gkw408
- HDOCK: a web server for protein–protein and protein–DNA/RNA docking based on a hybrid strategy.Nucleic Acids Res. 2017; 45: W365-W373https://doi.org/10.1093/nar/gkx407
- The MRN complex in double-strand break repair and telomere maintenance.FEBS Lett. 2010; 584: 3682-3695https://doi.org/10.1016/j.febslet.2010.07.029
- Role of microRNAs in translation regulation and cancer.WJBC. 2017; 8: 45https://doi.org/10.4331/wjbc.v8.i1.45
- Identification of homologous human miRNAs as antivirals towards COVID-19 genome.Adv Cell Gene Ther. 2021; 4https://doi.org/10.1002/acg2.114
- Structural, molecular hybridization and network based identification of miR-373-3p and miR-520e-3p as regulators of NR4A2 human gene involved in neurodegeneration.Nucleosides Nucleotides Nucleic Acids. 2022; 41: 419-443https://doi.org/10.1080/15257770.2022.2048851
- Mutation spectra of the mrn (Mre11, rad50, nbs1/nbn) break sensor in cancer cells.Cancers. 2020; 12: 3794https://doi.org/10.3390/cancers12123794
- The importance of making ends meet: mutations in genes and altered expression of proteins of the MRN complex and cancer.Mutat Res. 2008; 659: 262-273https://doi.org/10.1016/j.mrrev.2008.05.005
- Patterns and mechanisms of structural variations in human cancer.Exp Mol Med. 2018; 50: 1-11https://doi.org/10.1038/s12276-018-0112-3
- Overexpression of the MRE11-RAD50-NBS1 (Mrn) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis.BMC Cancer. 2018; 18: 869https://doi.org/10.1186/s12885-018-4776-9
- High expression of mre11–rad50–nbs1 is associated with poor prognosis and chemoresistance in gastric cancer.AR. 2016; 36: 5237-5248https://doi.org/10.21873/anticanres.11094
- Gene-disease network analysis reveals functional modules in mendelian, complex and environmental diseases.PLoS ONE. 2011; 6: e20284https://doi.org/10.1371/journal.pone.0020284
- Rna interference: biology, mechanism, and applications.Microbiol Mol Biol Rev. 2003; 67: 657-685https://doi.org/10.1128/MMBR.67.4.657-685.2003
- Socs3, a major regulator of infection and inflammation.Front Immunol. 2014; 5https://doi.org/10.3389/fimmu.2014.00058
- Long noncoding RNA PVT1 promotes breast cancer proliferation and metastasis by binding miR-128-3p and UPF1.Breast Cancer Res. 2021; 23: 115https://doi.org/10.1186/s13058-021-01491-y
- Targeting the NFκB signaling pathways for breast cancer prevention and therapy.Curr Med Chem. 2015; 22: 264-289https://doi.org/10.2174/0929867321666141106124315
- Long noncoding RNA MALAT1 suppresses breast cancer metastasis.Nat Genet. 2018; 50: 1705-1715https://doi.org/10.1038/s41588-018-0252-3
- Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1–98.Breast Cancer Res. 2019; 21: 30https://doi.org/10.1186/s13058-019-1118-z
Article info
Publication history
Published online: September 08, 2022
Accepted:
September 3,
2022
Received in revised form:
August 25,
2022
Received:
May 4,
2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
